Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Trans-Arterial Chemoembolization Using Streptozotocin: A 10-Year Experience

被引:0
|
作者
Dhir, M. [1 ]
Marsh, J. [1 ]
Tsung, A. [1 ]
Amesur, N. B. [1 ]
Orons, P. [1 ]
Santos, E. [1 ]
Geller, D. A. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Surg Oncol, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P213
引用
收藏
页码:S114 / S114
页数:1
相关论文
共 50 条
  • [1] Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience
    Mashaal Dhir
    Ruchi Shrestha
    Jennifer L. Steel
    J. Wallis Marsh
    Allan Tsung
    Mitchel E. Tublin
    Nikhil B. Amesur
    Philip D. Orons
    Ernesto Santos
    David A. Geller
    [J]. Annals of Surgical Oncology, 2017, 24 : 450 - 459
  • [2] Initial Treatment of Unresectable Neuroendocrine Tumor Liver Metastases with Transarterial Chemoembolization using Streptozotocin: A 20-Year Experience
    Dhir, Mashaal
    Shrestha, Ruchi
    Steel, Jennifer L.
    Marsh, J. Wallis
    Tsung, Allan
    Tublin, Mitchel E.
    Amesur, Nikhil B.
    Orons, Philip D.
    Santos, Ernesto
    Geller, David A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (02) : 450 - 459
  • [3] Prognostic factors for patients undergoing trans-arterial chemoembolization (TACE) for the treatment of liver metastases from neuroendocrine tumors
    Dong, XD
    Yin, X
    Zeh, HJ
    Bartlett, DL
    Brown, CK
    Carr, BI
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 65 - 65
  • [4] EFFECTIVENESS OF TRANS-ARTERIAL EMBOLISATION OF LIVER NEUROENDOCRINE TUMOUR METASTASES
    Mandair, D. S.
    Bridgestock, H.
    Shah, T.
    Mangat, K.
    Olliff, S.
    Mahon, B.
    Hussain, S.
    Johnson, P.
    Palmer, D.
    [J]. GUT, 2011, 60
  • [5] Inhibition of tumor growth of colorectal liver metastases after trans-arterial chemoembolization using different chemoembolisats in a rat model
    Ziemann, C.
    Sperling, J.
    Malter, M.
    Keller, K.
    Roller, J.
    Dold, S.
    Kollmar, O.
    Laschke, M.
    Glanemann, M.
    Menger, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 47 - 47
  • [6] Treatment of hepatic metastases of neuroendocrine malignancies: a 10-year experience
    Dejong, CHC
    Parks, RW
    Currie, E
    Piris, J
    Redhead, DN
    Garden, OJ
    [J]. JOURNAL OF THE ROYAL COLLEGE OF SURGEONS OF EDINBURGH, 2002, 47 (02): : 495 - 499
  • [7] Precision pulmonary trans-arterial chemoembolization (PPTACE) plus percutaneous RFA for unresectable lung neoplasms: Initial experience in twelve cases
    Gadaleta, C.
    Catino, A.
    Rubini, G.
    Ranieri, G.
    Fazio, V.
    Gadaleta-Caldarola, G.
    Vinciarelli, G.
    Armenise, F.
    Gaudiano, A.
    Mattioli, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Trans-Arterial Embolization (TAE) is the Best Locoregional Treatment Option for Patients with Liver Metastases from Neuroendocrine Tumors
    Del Prete, M.
    Faggiano, A.
    Marotta, V
    Ramundo, V
    Marciello, F.
    Carratu, A. C.
    Colao, A.
    Fiore, F.
    [J]. NEUROENDOCRINOLOGY, 2012, 96 : 26 - 26
  • [9] Initial experience of concurrent chemoradiotherapy for unresectable pancreatic cancer using gemcitabine via intravenous and trans-arterial infusion.
    Uchia, N
    Notani, M
    Yamamoto, N
    Ishida, J
    Yoshigi, J
    Kitagaki, H
    Nio, Y
    Yano, S
    Itakura, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 375S - 375S
  • [10] Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival
    Mazzaglia, Peter J.
    Berber, Eren
    Milas, Mira
    Siperstein, Aflan E.
    [J]. SURGERY, 2007, 142 (01) : 10 - 19